OverviewSuggest Edit
AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.
AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.
Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation. ... Show more
| Type | Public | |
| Founded | 1999 | |
| HQ | Cambridge, GB | Map |
| Website | astrazeneca.com | |
| Employee Ratings | More |
Recent NewsAll News
- Innovative Report on Diabetes Drug Therapy Market 2019: With Top Leading Players like Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca
- Astrazeneca Pharma India reports standalone net profit of Rs 29.09 crore in the December 2018 quarter
- Stocks Radar: AstraZeneca Pharma, Chalet Hotels, Cummins India, Infosys, Sun Pharma
- Volumes soar at Astrazeneca Pharma India Ltd counter
Key People/Management at AstraZeneca
Leif Johansson
Non-Executive Chairman of the Board
Pascal Soriot
Executive Director and Chief Executive Officer
Marc Dunoyer
Executive Director and Chief Financial Officer
Graham Chipchase
Senior Independent Non-Executive Director
Genevieve Berger
Non-Executive Director
Philip Broadley
Non-Executive Director
Report incorrect company information
AstraZeneca Office Locations
AstraZeneca has offices in Cambridge, Bristol, Buckinghamshire, Chester and in 166 other locations
Shanghai, CN
43/F CITIC Square, 1168 Nan Jing Xi Road
Wedel, DE
Wedel, Tinsdaler Weg 183
Hong Kong, HK
18/F, Shui On Centre, 6-8 Harbour Road, Wanchai
Bangalore, IN
Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road
Osaka, JP
Grand Front Osaka Tower B, 3-1, Ofuka-cho, Kita-ku
London, GB
15 Stanhope Gate
Report incorrect company information
AstraZeneca Financials and Metrics
AstraZeneca Revenue
AstraZeneca's revenue was reported to be £22.46 b in FY, 2017
| GBP | |
|---|---|
Revenue (FY, 2017) | 22.5b |
Gross profit (FY, 2017) | 18.1b |
Gross profit margin (FY, 2017), % | 80.8% |
Net income (FY, 2017) | 2.9b |
EBITDA (FY, 2017) | 6.7b |
EBIT (FY, 2017) | 3.7b |
Market capitalization (13-Feb-2019) | 92.7b |
Closing stock price (13-Feb-2019) | 36.6 |
Cash (31-Dec-2017) | 3.3b |
EV | 91.6b |
AstraZeneca's current market capitalization is $92.7 b.
- Source: Company Filings
| GBP | FY, 1996 | FY, 1997 | FY, 1998 | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.4b | 5.2b | 5.5b | 11.4b | 12.1b | 11.4b | 11.1b | 10.5b | 11.5b | 14.0b | 13.5b | 14.8b | 19.8b | 16.9b | 19.6b | 19.1b | 23.0b | 22.5b |
Revenue growth, % | 1% | (9%) | (10%) | |||||||||||||||
Cost of goods sold | 2.2b | 2.0b | 2.2b | 3.7b | 3.7b | 3.1b | 2.8b | 2.5b | 2.8b | 3.1b | 2.7b | 3.2b | 4.1b | 3.5b | 4.3b | 3.6b | 4.1b | 4.3b |
Gross profit | 3.1b | 3.2b | 3.4b | 7.6b | 8.4b | 8.3b | 8.3b | 8.0b | 8.7b | 10.8b | 10.8b | 11.6b | 15.7b | 13.4b | 15.3b | 15.5b | 18.9b | 18.1b |
- Source: Company Filings
| GBP | FY, 1996 | FY, 1997 | FY, 1998 | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 259.0m | 303.0m | 206.0m | 265.0m | 683.0m | 489.0m | 453.0m | 409.0m | 565.0m | 2.9b | 3.6b | 2.9b | 2.7b | 6.1b | 4.7b | 4.8b | 5.0b | 3.3b |
Accounts Receivable | 935.0m | 969.0m | 1.1b | 1.8b | 1.8b | 1.7b | 1.7b | 1.8b | 1.9b | 2.2b | 2.2b | 2.7b | 3.5b | 3.6b | 3.5b | 3.6b | 2.6b | 2.8b |
Inventories | 681.0m | 728.0m | 798.0m | 1.3b | 1.4b | 1.7b | 1.6b | 1.7b | 1.6b | 1.3b | 1.2b | 1.1b | 1.0b | 1.3b | 1.4b | 1.7b | 2.3b | 3.0b |
Current Assets | 3.0b | 2.9b | 2.7b | 6.1b | 7.0b | 6.8b | 7.6b | 7.2b | 7.7b | 8.0b | 8.7b | 8.6b | 10.0b | 13.2b | 12.2b | 12.3b | 13.0b | 12.9b |
| GBP | FY, 1996 | FY, 1997 | FY, 1998 | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 655.0m | 736.0m | 715.0m | 704.0m | 1.7b | 2.1b | 1.8b | 1.7b | 2.1b | 2.8b | 3.1b | 2.8b | 3.8b | 1.7b | 913.3m | 2.2b | 3.4b | 2.9b |
Cash From Operating Activities | 1.1b | 1.2b | 1.2b | 1.9b | 2.8b | 2.6b | 3.5b | 2.4b | 3.2b | 3.9b | 3.9b | 3.8b | 5.5b | 4.9b | 5.2b | 4.0b | 4.1b | 3.6b |
Dividends Paid | 332.0m | 365.0m | 399.0m | 764.0m | 1.9b | 850.0m | 753.0m | 754.0m | 833.0m | 976.0m | 1.1b | 1.3b | 1.7b | 2.6b | 2.7b | |||
Cash From Financing Activities | (39.0m) | (32.0m) | (96.0m) | (112.0m) | (267.0m) | (665.0m) | (794.0m) | (811.0m) | (740.0m) | (2.7b) | (2.7b) | 3.0b | (4.0b) | (2.0b) | (2.0b) | 3.4b | (1.3b) | (2.9b) |
| GBP | Y, 2017 |
|---|---|
EV/EBITDA | 13.7 x |
EV/EBIT | 24.9 x |
EV/CFO | 25.6 x |
Revenue/Employee | 367.7k |
Debt/Equity | 0.2 x |
Financial Leverage | 4.2 x |
AstraZeneca Revenue Breakdown
AstraZeneca revenue breakdown by business segment: 22.3% from Respiratory, Inflammation and Autoimmunity, 23.8% from Infection, Neuroscience and Gastrointestinal:, 15.9% from Oncology and 38.1% from Cardiovascular and Metabolic Diseases
Report incorrect company information
AstraZeneca Online and Social Media Presence
152.26k Twitter followers
AstraZeneca has 152.26k Twitter Followers. The number of followers has increased 0.6% month over month and increased 2% quarter over quarter
Report incorrect company information
AstraZeneca News and Updates
February 08, 2019
Innovative Report on Diabetes Drug Therapy Market 2019: With Top Leading Players like Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is …
February 07, 2019
Astrazeneca Pharma India reports standalone net profit of Rs 29.09 crore in the December 2018 quarter
Sales rise 67.41% to Rs 215.19 crore
February 07, 2019
Stocks Radar: AstraZeneca Pharma, Chalet Hotels, Cummins India, Infosys, Sun Pharma
Here are the stocks moving the market this morning.
February 07, 2019
Volumes soar at Astrazeneca Pharma India Ltd counter
Astrazeneca Pharma India Ltd clocked volume of 12854 shares by 10:49 IST on BSE, a 13.2 times surge over two-week average daily volume of 974 shares
February 07, 2019
AstraZeneca Pharma sizzles after turnaround Q3 result
AstraZeneca Pharma India jumped 10.37% to Rs 1,772.70 at 09:25 IST on BSE after the company reported net profit of Rs 29.09 crore in Q3 December 2018 as against net loss of Rs 10.35 crore in Q3 December 2017.
February 06, 2019
Worldwide Vaccines Market 2019: Is Likely Expand Tremendous Growth In Near Future GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Abbott, Pfizer, Mitsubishi Tanabe Pharma, LG Life Sciences
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. Poste…
Report incorrect company information
AstraZeneca Blogs
Show more
AstraZeneca Company Life and Culture
Report incorrect company information
AstraZeneca Frequently Asked Questions
When was AstraZeneca founded?
AstraZeneca was founded in 1999.
Who are AstraZeneca key executives?
AstraZeneca's key executives are Leif Johansson, Pascal Soriot and Marc Dunoyer.
How many employees does AstraZeneca have?
AstraZeneca has 61,100 employees.
What is AstraZeneca revenue?
Latest AstraZeneca annual revenue is £22.5 b.
What is AstraZeneca revenue per employee?
Latest AstraZeneca revenue per employee is £367.7 k.
Who are AstraZeneca competitors?
Competitors of AstraZeneca include Teva Pharmaceuticals, Bristol-Myers Squibb and Bayer.
Where are AstraZeneca offices?
AstraZeneca has offices in Cambridge, Bristol, Buckinghamshire, Chester and in 166 other locations.
How many offices does AstraZeneca have?
AstraZeneca has 171 offices.